SBSW SBSW
Company Profile ↓Company Overview
SBSW (SBSW) is a publicly traded company listed on with a market capitalization of $28.08B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Return on capital employed stands at 21.7%.
Operating margin of 19.3% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $129.68B (+15.6% YoY); net profit $-5.17B.
- Trailing 12 Months Year-on-year growth — revenue +15.7%.
- 5-Year Trend Long-term compounding — revenue CAGR -2.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -2.12% |
| 1 Year: | 15.65% |
Stock Price Performance
| 1 Year: | +16.66% |
| 6 Months: | -41.70% |
| 3 Months: | -15.36% |
| 1 Month: | +16.43% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)63.09 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 21.7%.
- Generates positive free cash flow.
CONS
- Revenue declined at -2.1% CAGR over 5 years.
- Trading 51.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 138.29B | 113.68B | 112.13B | 129.68B |
| Cost of Revenue | - | 103.69B | 100.90B | 105.82B | 98.97B |
| Gross Profit | - | 34.59B | 12.78B | 6.30B | 30.71B |
| Operating Expenses | - | 1.77B | 4.36B | 2.62B | 5.65B |
| Operating Income | - | 32.82B | 8.42B | 3.68B | 25.06B |
| EBITDA | - | 37.13B | -27.52B | 7.86B | 12.67B |
| Interest Expense | - | 2.13B | 2.31B | 3.27B | 3.71B |
| Pretax Income | - | 27.90B | -39.85B | -4.21B | -411.00M |
| Tax Provision | - | 8.92B | -2.42B | 1.50B | 4.33B |
| Net Income | - | 18.40B | -37.77B | -7.30B | -5.17B |
| Diluted EPS | - | 26.00 | -53.36 | -10.32 | -7.32 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 166.63B | 142.94B | 138.09B | 149.74B |
| Current Assets | - | 60.76B | 61.82B | 48.41B | 60.75B |
| Cash & Equivalents | - | 26.08B | 25.56B | 16.05B | 17.18B |
| Inventory | - | 26.38B | 26.36B | 25.55B | 31.48B |
| Receivables | - | 5.83B | 6.67B | 3.67B | 4.83B |
| Total Liabilities | - | 75.63B | 91.33B | 89.80B | 105.57B |
| Current Liabilities | - | 20.22B | 36.41B | 20.95B | 34.16B |
| Long Term Debt | - | 22.61B | 24.95B | 41.13B | 31.86B |
| Total Debt | - | 23.05B | 41.01B | 42.06B | 43.90B |
| Total Equity | - | 88.10B | 48.73B | 43.98B | 39.53B |
| Shares Outstanding | - | 2.83B | 2.83B | 2.83B | 2.83B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 15.54B | 7.09B | 10.11B | 21.41B |
| Investing Cash Flow | - | -17.37B | -22.04B | -24.34B | -21.69B |
| Financing Cash Flow | - | -3.50B | 12.98B | 4.74B | 2.76B |
| Capital Expenditure | - | -15.90B | -22.41B | -21.57B | -20.31B |
| Free Cash Flow | - | -356.00M | -15.32B | -11.46B | 1.10B |
| Net Change in Cash | - | -5.33B | -1.97B | -9.49B | 2.47B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 25.0% | 11.2% | 5.6% | 23.7% |
| Operating Margin % | - | 23.7% | 7.4% | 3.3% | 19.3% |
| Net Margin % | - | 13.3% | -33.2% | -6.5% | -4.0% |
| ROE % | - | 20.9% | -77.5% | -16.6% | -13.1% |
| ROCE % | - | 22.4% | 7.9% | 3.1% | 21.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SBSW
Is Sibanye-Stillwater (SBSW) One of the Best African Stocks to Buy According to Hedge Funds?
Sibanye-Stillwater Limited (NYSE:SBSW) is one of the best Middle East and Africa stocks to buy according to hedge funds. On May 13, Sibanye-Stillwater Limited (NYSE:SBSW) announced the results of its cash tender offer to retire all outstand…
Sibanye Stillwater Limited ("Sibanye-Stillwater" or the "Group"), through its wholly-owned subsidiary, Stillwater Mining Company (the "Offeror"), announced today its offers to purchase for cash of its 4.000% Senior Notes due 2026 and 4.500% Senior Notes due 2029
Sibanye Stillwater Limited ("Sibanye-Stillwater" or the "Group"), through its wholly-owned subsidiary, Stillwater Mining Company (the "Offeror"), announced today its offers to purchase for cash the securities listed below (the "Offers"). Th…
Best Income Stocks to Buy for April 23rd
ZTO, SBSW and ARCAY made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 23rd, 2026.
Down 29.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Sibanye Gold Limited (SBSW)
Sibanye Gold Limited (SBSW) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, i…
The Tape Says Buy — These 3 Growth Stocks Are the Obvious Trade Right Now
Finding top growth stocks to buy that not only have the solid underlying fundamentals that support their investment theses over the long-term, but also have excellent technical fundamentals supporting their near and medium-term outlooks isn…
Best Momentum Stock to Buy for March 3rd
SBSW, FIGS and DPMLF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 3, 2026.
SBSW — Frequently Asked Questions
What is the current share price of SBSW?
As of 2026-08-05 17:25 PDT, SBSW trades at $9.92 on NASDAQ/NYSE. Its 52-week range is $7.06 to $20.52.
What is the market capitalisation of SBSW?
SBSW has a market capitalisation of $28.08B on NASDAQ/NYSE.
What is the P/E ratio of SBSW?
SBSW trades at a trailing price-to-earnings (P/E) ratio of -1.36. Its price-to-book (P/B) ratio is 0.71.
What is the return on equity (ROE) of SBSW?
SBSW has a return on equity (ROE) of -13.08%. Its return on capital employed (ROCE) is 21.68%.
Is SBSW a good stock to buy?
This page provides a data-driven analysis of SBSW, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.